COVID‐19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease‐Modifying Antirheumatic Drugs on Clinical Outcomes
Study (n=103 confirmed/high suspicion COVID‐19) found hospitalisation was associated with older age (P < 0.001); hypertension (P = 0.001); chronic obstructive pulmonary disease (P = 0.02) and oral glucocorticoids (P < 0.001) but not maintenance anticytokine biologic therapies.
Source:
Arthritis & Rheumatology